w 7 has been researched along with Acute Myelogenous Leukemia in 2 studies
W 7: RN given refers to parent cpd; structure; calmodulin antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ina, Y | 1 |
| Koide, Y | 1 |
| Nezu, N | 1 |
| Yoshida, TO | 1 |
| Chapekar, MS | 1 |
| Hartman, KD | 1 |
| Knode, MC | 1 |
| Glazer, RI | 1 |
2 other studies available for w 7 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Regulation of HLA class II antigen expression: intracellular signaling molecules responsible for the regulation by IFN-gamma and cross-linking of Fc receptors in HL-60 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Neoplasm; Calcimycin; Calcium; Calmodulin; | 1987 |
Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Calcimycin; Calmodulin; Cell Differentiation; Cell Li | 1987 |